CTCX Carmell Therapeutics: Rasio rega marang prakiraan pendapatan

Carmell Corporation - logo grafis emiten CTCX

Carmell Corporation is developing advanced nano-polymers for tissue regeneration. The forward price-to-sales valuation demonstrates price action where the value 1.60 describes the current level. Growth is driven by demand from aesthetic medicine clinics for plasma platforms. The primary catalysts are the commercialization of wound-healing products and expansion into the orthopedic sector.

Carmell - Rasio kapitalisasi marang dodolan sing dikarepake CTCX (periode 05.04.2024 - 31.12.2024)

Ringkesan rincian data analitis Carmell Corporation (CTCX)

- rega pasar lan target rega analis:
Analisis kabeh metrik perusahaan:Carmell Corp. CTCX
Produk asli Carmell Therapeutics

Carmell Corporation (CTCX) is optimizing costs by utilizing a flexible network of contract laboratories for the production of biomaterials and packaging. The forward P/S ratio measures market value relative to expected revenue, reflecting the business's ability to pass inflation onto consumers, which, combined with the expected P/S dynamics on GURU.Markets, allows investors to distinguish between searching for a market bottom and a dangerous value trap.

Pesaing Carmell Corporation

Rasio rega marang prakiraan pendapatan ascendispharma.com ASND|Madrigal Corp (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MoonLake Corp|Crinetics Corp (CRNX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan newamsterdampharma.com (NAMS)|Multiplikator forward rega marang pendapatan soleno.life SLNO|Multiplikator Forward P/S FOLD (amicusrx.com)|Rasio kapitalisasi marang dodolan sing dikarepake 89bio (ETNB)|Agios - Multiplikator Forward P/S|Structure Corp - Rasio rega marang pendapatan sing dikarepake|mimedx.com (MDXG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan MBX|Rasio rega marang prakiraan pendapatan Altimmune Pharma (ALT)|Rasio rega marang prakiraan pendapatan AARD (Aardvark Therapeutics Corp)|Multiplikator Forward P/S SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BMEA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Multiplikator forward rega marang pendapatan|vTv Therapeutics, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Agape ATP Corp.|Multiplikator forward rega marang pendapatan Pluri (PLUR)|Multiplikator Forward P/S SYBX|Rasio kapitalisasi marang dodolan sing dikarepake Lipocine Inc|Rasio rega marang prakiraan pendapatan Matinas BioPharma Holdings MTNB|Rasio kapitalisasi marang dodolan sing dikarepake Spruce Biosciences (SPRB)|GLTO: Multiplikator forward rega marang pendapatan|LUMO - Multiplikator Forward P/S|ONVO: Multiplikator Forward P/S|RDUS (Radius Recycling) - Rasio rega marang prakiraan pendapatan